Month: September 2020

VirusIQ selects the WISeKey Digital Health Passport for COVID-19 to secure digital health screening, telemedicine and diagnostic servicesGeneva – September 24, 2020 – WISeKey International Holding (“WISeKey”, SIX: WIHN, NASDAQ: WKEY), a leading cybersecurity and IoT company, signed a Strategic Collaboration Agreement with ClinIQ Inc, a healthcare incubator platform, to secure digital health screening, telemedicine and diagnostic services.   ClinIQ Inc has worked with Oxford University Innovation to launch VirusIQ is a screening platform that specialises in early detection, prevention and management of virus diseases such as COVID-19. The screening platform provides private, secure and safe identity management, digital health screening, telemedicine and diagnostic services.The collaboration with ClinIQ reinforces WISeKey’s main objective...

Collaboration with CGN Nuclear Technology Development Co., Ltd  worth a minimum of EUR 100 millionLouvain-La-Neuve, Belgium, 24 September  2020 – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today that it has received the first payment of EUR 20 million from CGN Dasheng Electron Accelerator Technology Co., Ltd (“CGN Dasheng”). This follows the signature on 26 August 2020 of a strategic licensing deal with CGN Nuclear Technology Development Co., Ltd. (“CGNNT”), and its wholly-owned subsidiary CGN Dasheng, for the exclusive rights to IBA’s Proteus®PLUS* technology in China (see the press release here).The overall minimum deal value to IBA is EUR 100 million.Olivier Legrain, Chief Executive Officer at IBA, commented: “IBA identified China...

Premier paiement d’EUR 20 millions pour l’accord de licence stratégique en ChineCollaboration avec CGN Nuclear Technology Development Co., Ltdd’une valeur minimale d’EUR 100 millionsLouvain-La-Neuve, Belgium, 24 septembre 2020 – IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce aujourd’hui avoir reçu le premier paiement d’EUR 20 millions de la part de CGN Dasheng Electron Accelerator Technology Co., Ltd (“CGN Dasheng”). Ce versement fait suite à la signature d’un accord de licence stratégique, annoncée le 26 août 2020, avec CGN Nuclear Technology Development Co., Ltd. (“CGNNT”), et sa filiale en propriété exclusive CGN Dasheng, pour les droits exclusifs sur la technologie Proteus®PLUS d’IBA en Chine (voir le communiqué de presse). La...

Press Release Nokia and Optus to provide IoT software solutions to Australian mining, utilities and transportation industries  Collaboration combines Nokia’s IMPACT IoT Platform with Optus services expertise and market reach Australia’s IoT market estimated to grow to USD 25 billion by 2024 24 September 2020 Sydney, Australia – Optus has selected Nokia’s IMPACT Internet of Things (IoT) platform to provide device management and data collection capabilities to their customers. Both companies have agreed on a joint go-to-market strategy to bring IoT solutions to Optus customers across multiple industry segments in Australia.Nokia’s industry leading IoT Device Management Platform (DMP) will enable Optus to provide its customers with simple access to Narrow Band-IoT device data, from low power devices, and remote device management at...

EMERYVILLE, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq: ZGNX) today announced the pricing of its offering of $200,000,000 aggregate principal amount of 2.75% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on September 28, 2020, subject to customary closing conditions. Zogenix also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date notes are first issued, up to an additional $30,000,000 principal amount of notes.The notes will be senior, unsecured obligations of Zogenix and will accrue interest at a rate of 2.75% per annum,...

紐約州水牛城, Sept. 24, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX) 是一家致力研究、開發及商業化用於治療癌症及相關疾病的新療法的全球生物製藥公司，今天宣佈，美國食品和藥品管理局 (FDA) 批准其 TCRT-ESO-A2 的研究性新藥 (IND) 申請，TCRT-ESO-A2 是一種以實體腫瘤為標靶的自體 T 細胞受體 (TCR)-T 細胞療法，其在 HLA-A*02:01 陽性患者中為 NY-ESO-1 陽性。TCRT-REX-A2 由 Axis Therapeutics Limited 開發，這是 Athenex 與香雪生命科學研究中心（「XLifeSc」）的合資企業，XLifeSC 是香雪製藥股份有限公司（深圳交易所：300147）的子公司。TCRT-REX-A2 類似 TAEST16001，是一種在中國由 XLifeSc 同時開發用於臨床應用的自身細胞為基礎的療法，因為兩種療法都具有相同的親和力增強 TCR。 Athenex 主席兼行政總裁暨 Axis Therapeutics 行政總裁 Johnson Lau 博士說：「FDA 批准 TCRT-ESO-A2 的 IND 申請是 Athenex 的另一個重要里程碑，讓我們進一步擴展基於 T 細胞的癌症免疫療法領域的腫瘤學產品系列。對於這次 IND 申請獲批，我們感到非常高興，這代表 Athenex 已有 10 項 IND 獲得 FDA 批准。我們亦對我們的合作夥伴 XLifeSc 使用 TAEST16001 在中國進行的初步研究中觀察到的初步陽性臨床訊號感到興奮。」香雪製藥主席兼行政總裁王永輝先生表示：「TCRT-ESO-A2 取得此項成就緊隨國家藥品監督管理局授予 TAEST16001 在中國的 IND，並代表我們在 Axis Therapeutics 的聯合開發團隊的成功合作。XLifeSc 已開始在中國對 TAEST16001...

MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for TLX591-CDx (Kit for the preparation of 68Ga-PSMA-11), a radiopharmaceutical targeting Prostate-Specific Membrane Antigen (PSMA) for the imaging of prostate cancer using Positron Emission Tomography (PET).1Telix’s NDA submission for TLX591-CDx includes clinical data from over 600 patients obtained from both prospective and retrospective clinical studies performed by Telix or in collaboration. The submission also builds on definitive peer-reviewed clinical research conducted at leading academic centres including the University of California, Los Angeles (USA), the Peter MacCallum...

Non-dilutive financing to fund continued growth including accelerating sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patientsCompany financials will now be filed on September 30, 2020 with management–hosted earnings call on October 1, 2020 at 10 a.m. ESTTORONTO, Sept. 23, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of cannabis, is pleased to announce that it has entered into a binding term sheet for a credit facility (“Credit Facility”) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“LPF”). The $30 million Credit Facility, maturing in August 2022, will be used for general working capital purposes, capital expenditures and general...

TORONTO, Sept. 23, 2020 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that its board of directors (the “Board”) has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on October 15, 2020 to holders of Common Shares of record on September 30, 2020.The Company also offers a Dividend Reinvestment Plan (the “Plan”), which is eligible to holders of Common Shares and provides a convenient means to purchase additional Common Shares by reinvesting cash dividends at a potential discount and without having to pay commissions, service charges or brokerage fees.Pursuant to the Plan and at the discretion of Timbercreek Capital Inc., the Manager, Common Shares will be acquired in the open market at prevailing prices or issued from treasury at 98 percent...

ATLANTA, Ga., Sept. 23, 2020 (GLOBE NEWSWIRE) — Select Interior Concepts, Inc. (“SIC” or the “Company”) (NASDAQ: SIC), a premier installer and nationwide distributor of interior building products, today announced that its Residential Design Services (RDS) subsidiary continues to further launch its Momentum Design™ virtual design studio platform with home builders. For the most recent launch, RDS has partnered with Woodside Homes for their new Villas at Cypress Ridge community development in Phoenix, AZ.“Many builders are getting away from personalization capabilities, but Woodside Homes understands how important choice is for our homebuyers. We chose RDS and their Momentum Design™ platform because it allowed our buyers to virtually see what their selections will look like in their new home and not just rely on small samples.“Our...